PranaX Corporation Closes $17 million Oversubscribed Series A Round
HOUSTON, Jan. 29, 2026 /PRNewswire/ — PranaX Corporation, a leading biotechnology company focused on regenerative biologics, today announced the closing of its oversubscribed $17 million Series A financing. The Series A round was led by family offices,…